Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 8th, 2023%
The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration. . . . → Read More: Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track
By Alan, on December 7th, 2023%
A developer of treatments for brain disorders and researchers at Stanford University aim to harness ultrasound to deliver drugs in nanoscale particles to precise regions of the brain. . . . → Read More: Biotech, Academic Labs Partner on Ultrasound Brain Therapy
By Alan, on December 4th, 2023%
A company developing DNA into a feasible method for large-scale data storage unveiled a credit card-sized device using DNA for off-line data storage. . . . → Read More: DNA Data Company Creates Portable Storage Media
By Alan, on December 1st, 2023%
A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders. . . . → Read More: Partnership to Discover Mental Health Peptides in Milk
By Alan, on November 30th, 2023%
A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures. . . . → Read More: Study to Provide Real World Data for A.I. Seizure Forecasts
By Alan, on November 28th, 2023%
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions. . . . → Read More: Trial Set to Test Inhaled mRNA for Viral Infections
By Alan, on November 25th, 2023%
According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017. . . . → Read More: Infographic: A.I. Getting Hype, But Fewer Venture Funds
By Alan, on November 22nd, 2023%
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding. . . . → Read More: Lab-Grown Tissue Company Gains $38M in Seed Funds
By Alan, on November 21st, 2023%
A challenge competition with a $50 million purse seeks new strategies to attack the global substance abuse epidemic, including personalized diagnostics and treatments. . . . → Read More: Challenge Seeks Precise Addiction Strategies, Biomarkers, Treatments
By Alan, on November 20th, 2023%
Data from three health repositories show a simple blood test reveals inherited and acquired genetic indicators, analyzed with artificial intelligence, to detect coronary heart disease. . . . → Read More: A.I. Analytics Show Blood Test Detects Heart Disease
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|